LCN2 is also up-regulated in some cancers, including breast, cervical and pancreatic cancer, and LCN2 expression correlates with increased invasiveness and poor prognosis [89,90,91,92]. The gene discussed is LCN2; the disease is familial pancreatic carcinoma.